trending Market Intelligence /marketintelligence/en/news-insights/trending/ggrpbyak9a6s42fq9g15ta2 content esgSubNav
In This List

Evolus appoints CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Evolus appoints CFO

Evolus Inc. appointed Lauren Silvernail as CFO and executive vice president of corporate development.

Silvernail joined the company from Revance Therapeutics Inc., where she most recently served as CFO and chief business officer.

Irvine, Calif.-based Evolus is a pharmaceutical company, which manufactures clinical neurotoxins used in cosmetic surgery.